India vaccination

Phase-3 Trials Show Covaxin 93.4 Per Cent Effective Against Severe COVID-19 But Supply Marred By Delay In Manufacturing
Phase-3 Trials Show Covaxin 93.4 Per Cent Effective Against Severe COVID-19 But Supply Marred By Delay In ManufacturingSwarajya StaffJul 4, 2021 05:48 PM +05:30 IST
What The Experts Say On How A Third Wave Can Be Delayed And Made Weaker
What The Experts Say On How A Third Wave Can Be Delayed And Made Weaker Bhaswati Guha Majumder Jun 25, 2021 08:19 PM +05:30 IST
India's Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas Regulators
India's Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas RegulatorsSwarajya StaffJun 2, 2021 11:01 AM +05:30 IST
Memo To Chief Ministers: Vaccinate Your Cities First To End The Pandemic Faster
Memo To Chief Ministers: Vaccinate Your Cities First To End The Pandemic FasterArihant Pawariya Apr 28, 2021 08:12 PM +05:30 IST
Load More